• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai , March 11

MUMBAI-BASED pharma major Nicholas Piramal India Ltd has saiday that its annual profit would be lower by Rs 50 lakh due to the price cut on certain drugs and formulations effected by the Government earlier this month.

Through its notification issued on March 3rd and 9th, 2004, the National Pharmaceutical Pricing had announced price cuts on a number of bulk drugs and formulations. NPIL informed the BSE that products in the company's portfolio that were expected to take the hit, following the said notifications, include drug intermediates Vitamin A Palmitate, Vitamin A Acetate and Dry Vitamin A Acetate 500; Vitamin A chewable tablets Aerovit and psychiatric drug Mazetol (Carbamazepine).

More Stories on : Outlook | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
A.L. Mudaliar steps down as Bata India chief

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line